Abstract
Background
The impact of structural heart disease (SHD) on safety and efficacy of catheter ablation of cavo-tricuspid isthmus-dependent atrial flutter (AFLU) is unclear. In addition, recent data suggest a higher complication rate of AFLU ablation compared to the more complex atrial fibrillation (AF) ablation procedure.
Methods and results
Within our prospective multicenter registry, 3526 consecutive patients underwent AFLU ablation at 49 German electrophysiological centers from 2007 to 2010. For the present analysis, the patients were divided into a group with SHD (n = 2164 [61.4%]; median age 69 years; 78.5% male) and a group without SHD (n = 1362 [38.6%]; 65 years; 70.3% male). In our study, SHD mainly encompasses coronary artery disease (52.6%), left ventricular ejection fraction ≤ 50% (47.6%), and hypertensive heart disease (28.0%). The primary ablation success (97%) and the incidence of major (0.2%) or moderate (1.2%) complications did not differ significantly between the two groups (P = 1.0 and 0.87, respectively). Vascular access site complications (0.6%), AV block III° (0.2%), and bleeding (≥ BARC II: 0.2%) were most common. After a median 562 days of follow-up, we observed a 2.92-fold higher one-year mortality (P < 0.0001) in patients with SHD. Patients’ satisfaction with the ablation therapy (72.0% satisfied) was close to the overall subjective tachyarrhythmia-free rate (70.7%).
Conclusions
The present analysis demonstrates that ablation of cavo-tricuspid isthmus dependent AFLU in patients with SHD has a comparable, excellent risk-benefit profile in our large “real-world” registry. Mortality rates expectedly are higher in patients with SHD and AFLU compared to patients without SHD.
ClinicalTrials.gov
NCT01197638, http://clinicaltrials.gov/ct2/show/NCT01197638
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AMI:
-
Acute myocardial infarction
- CI:
-
Confidence interval
- IQR:
-
Interquartile range
- MACE:
-
Major adverse cardiac event
- MACCE:
-
Major adverse cardiac and cerebrovascular event
- NF:
-
Nonfatal
References
Perez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol. 2009;2:393–401.
Eckardt L, Frommeyer G, Sommer P, Steven D, Deneke T, Estner HL, et al. Updated survey on interventional electrophysiology: 5-year follow-up of infrastructure, procedures, and training positions in Germany. JACC Clin Electrophysiol. 2018;4:820–7.
Inama G, Pedrinazzi C, Adragao P, Alvarez M, Arribas F, Bonhorst D, et al. Five years of catheter ablation procedures in South-Western Europe: meta-analysis of National Registries. Pacing Clin Electrophysiol. 2009;32:506–15.
Kesek M. Ablation procedures in Sweden during 2007: results from the Swedish Catheter Ablation Registry. Europace. 2009;11:152–4.
Steinbeck G, Sinner MF, Lutz M, Muller-Nurasyid M, Kaab S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. Eur Heart J. 2018;39:4020–9.
Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, et al. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German Ablation Registry. Eur Heart J. 2017;38:1317–26.
Calkins H, Canby R, Weiss R, Taylor G, Wells P, Chinitz L, et al. Results of catheter ablation of typical atrial flutter. Am J Cardiol. 2004;94:437–42.
Da Costa A, Faure E, Thevenin J, Messier M, Bernard S, Abdel K, et al. Effect of isthmus anatomy and ablation catheter on radiofrequency catheter ablation of the cavotricuspid isthmus. Circulation. 2004;110:1030–5.
Lewalter T, Weiss C, Spencker S, Jung W, Haverkamp W, Willems S, et al. Gold vs. platinum-iridium tip catheter for cavotricuspid isthmus ablation: the AURUM 8 study. Europace. 2011;13:102–8.
Schmieder S, Ndrepepa G, Dong J, Zrenner B, Schreieck J, Schneider MA, et al. Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J. 2003;24:956–62.
Gilligan DM, Zakaib JS, Fuller I, Shepard RK, Dan D, Wood MA, et al. Long-term outcome of patients after successful radiofrequency ablation for typical atrial flutter. Pacing Clin Electrophysiol. 2003;26:53–8.
Rodgers M, McKenna C, Palmer S, Chambers D, Van Hout S, Golder S, et al. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Health Technol Assess. 2008;12:iii-iv, xi-xiii, 1–198.
Funding sources
The work was supported by an unrestricted grant from foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen (Ludwigshafen, Germany).
Disclosures
No author has a relevant conflict of interest in relation to this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dechering, D.G., Gonska, BD., Brachmann, J. et al. Efficacy and complications of cavo-tricuspid isthmus-dependent atrial flutter ablation in patients with and without structural heart disease: results from the German Ablation Registry. J Interv Card Electrophysiol 61, 55–62 (2021). https://doi.org/10.1007/s10840-020-00769-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-020-00769-z